news

Cailianshe reported on August 9th,Sinopharm GroupIn the morning announcement on August 9, the company noticed that on August 8, news about Shanxi Aorui Biomaterials Co., Ltd. suspected of illegally producing "allogeneic bone implant materials" appeared on the Internet, which aroused widespread social concern, and some media erroneously recorded that Sinopharm Group was involved. In order to avoid misleading investors, the relevant situation is explained as follows: The subject involved in the relevant media reports is not Sinopharm Group. Sinopharm Group's main business is pharmaceutical wholesale, mainly drug operations. Sinopharm Group has no business dealings with Shanxi Aorui Biomaterials Co., Ltd., nor any relationship.